Does AREDIA Cause Second primary malignancy? 31 Reports in FDA Database

Q: Does AREDIA cause Second primary malignancy?

31 reports of Second primary malignancy have been filed with the FDA for AREDIA, representing 18.8% of all AREDIA adverse event reports.

Q: How dangerous is Second primary malignancy from AREDIA?

Of 31 reports, 7 (22.6%) resulted in death and 20 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Second primary malignancy have been filed in association with AREDIA. This represents 18.8% of all adverse event reports for AREDIA.

Reports of Second primary malignancy with AREDIA

18.8%

of all AREDIA reports

Deaths

Hospitalizations

How Dangerous Is Second primary malignancy From AREDIA?

Of the 31 reports, 7 (22.6%) resulted in death, 20 (64.5%) required hospitalization.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AREDIA. However, 31 reports have been filed with the FAERS database.

What Other Side Effects Does AREDIA Cause?

Osteonecrosis of jaw (151) Pain (128) Anxiety (122) Spinal osteoarthritis (114) Osteoarthritis (113) Dyspnoea (107) Arthralgia (102) Osteomyelitis (95) Anaemia (89) Atelectasis (89)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Which AREDIA Alternatives Have Lower Second primary malignancy Risk?

AREDIA vs ARFORMOTEROL AREDIA vs ARGATROBAN AREDIA vs ARGININE AREDIA vs ARGININE\LYSINE AREDIA vs ARIMIDEX

AREDIA Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy AREDIA Demographics